New research from Australia's WEHI reveals that the cancer drug target MCL-1, while blocking cancer cell survival, also powers energy in healthy cells. This explains harmful side effects in organs like the heart and liver. Findings may lead to safer therapies that spare healthy tissue while effectively killing cancer.